-transparent.png){kind=logo}
BACKGROUND Iodine-nonreactive lesions of esophageal epithelium often are associated with dysplasia and carcinoma. The authors examined the usefulness of telomerase activity as an indicator for esophageal carcinogenesis in such lesions. METHODS Telomerase activity was measured using the telomeric repeat amplification protocol assay in 18 samples of iodine-nonreactive lesions apart from the primary tumor in surgically resected specimens obtained from patients with esophageal squamous cell carcinoma (ESCC) and 55 endoscopic punch biopsies of iodine-nonreactive lesions obtained from 25 patients with ESCC and 30 patients who had undergone endoscopic examination for other reasons. RESULTS Ten of 18 iodine-nonreactive samples (56%) obtained from surgically resected specimens showed telomerase activity. In all ten telomerase positive samples, carcinoma in situ (CIS) was observed in iodine-nonreactive mucosa by light microscopy. In eight telomerase negative samples, no tumor tissue was observed in iodine-nonreactive lesions. In a parallel study, telomerase activity was detected in 28 of 55 endoscopic punch biopsy specimens (51%). CIS was observed in 25 of 28 iodine-nonreactive lesions with positive telomerase activity (89%), and tumor tissue was not observed in the other 3 samples (11%), which included 2 cases of severe dysplasia and 1 case of moderate dysplasia. No tumor tissue was observed in any of the 27 telomerase negative samples. CONCLUSIONS Positive and negative telomerase activity was found to be correlated with the presence and absence, respectively, of immortalized tumor cells in iodine-nonreactive lesions. The measurement of telomerase activity in iodine-nonreactive lesions independently contributes to the selection of an appropriate therapeutic strategy.
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
August 1998,
Cancer,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
March 2000,
BJU international,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
February 2002,
International journal of clinical oncology,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
June 1997,
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
September 1997,
The Journal of pathology,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
April 2000,
The American journal of pathology,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
July 1980,
Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
April 2000,
Lung cancer (Amsterdam, Netherlands),
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
February 1998,
Clinical cancer research : an official journal of the American Association for Cancer Research,
K Koyanagi, and
S Ozawa, and
N Ando, and
M Mukai, and
Y Kitagawa, and
M Ueda, and
M Kitajima
October 1998,
British journal of cancer,
